{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T10:21:05Z","timestamp":1772533265222,"version":"3.50.1"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.bone.2020.115370","type":"journal-article","created":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T20:52:30Z","timestamp":1587415950000},"page":"115370","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Disruption of the aldehyde dehydrogenase 2 gene increases the bone anabolic response to intermittent PTH treatment in an ovariectomized mouse model"],"prefix":"10.1016","volume":"136","author":[{"given":"Kenji","family":"Kosugi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7646-3461","authenticated-orcid":false,"given":"Takafumi","family":"Tajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunitaka","family":"Menuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kayoko Furukawa","family":"Okuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kotaro","family":"Tokuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hokuto","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuaki","family":"Okada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4577-5072","authenticated-orcid":false,"given":"Manabu","family":"Tsukamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiaki","family":"Yamanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukichi","family":"Zenke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akinori","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2020.115370_bb0005","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1359\/jbmr.2000.15.4.721","article-title":"Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis","volume":"15","author":"Klotzbuecher","year":"2000","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2020.115370_bb0010","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/S0140-6736(02)08657-9","article-title":"Epidemiology and outcomes of osteoporotic fractures","volume":"359","author":"Cummings","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.bone.2020.115370_bb0015","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF01623184","article-title":"Hip fractures in the elderly: a world-wide projection","volume":"2","author":"Cooper","year":"1992","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2020.115370_bb0020","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1210\/er.2004-0006","article-title":"Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use","volume":"26","author":"Hodsman","year":"2005","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.bone.2020.115370_bb0025","first-page":"690","article-title":"Anabolic actions of parathyroid hormone on bone","volume":"14","author":"Dempster","year":"1993","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.bone.2020.115370_bb0030","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1172\/JCI6610","article-title":"Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone","volume":"104","author":"Jilka","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2020.115370_bb0035","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1210\/endo.136.8.7628403","article-title":"Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cells","volume":"136","author":"Dobnig","year":"1995","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2020.115370_bb0040","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis","volume":"344","author":"Neer","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2020.115370_bb0045","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.bone.2006.06.007","article-title":"Response rate of bone mineral density to teriparatide in postmenopausal women with osteoporosis","volume":"39","author":"Gallagher","year":"2006","journal-title":"Bone"},{"key":"10.1016\/j.bone.2020.115370_bb0050","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s11420-016-9537-1","article-title":"Bone mineral density response from teriparatide in patients with osteoporosis","volume":"13","author":"Kim","year":"2017","journal-title":"HSS J."},{"key":"10.1016\/j.bone.2020.115370_bb0055","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1007\/s00198-016-3581-z","article-title":"A retrospective analysis of nonresponse to daily teriparatide treatment","volume":"27","author":"Niimi","year":"2016","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2020.115370_bb0060","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1046\/j.1432-1327.1998.2510549.x","article-title":"Human aldehyde dehydrogenase gene family","volume":"251","author":"Yoshida","year":"1998","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bone.2020.115370_bb0065","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/BF00197271","article-title":"Distribution of ADH2 and ALDH2 genotypes in different populations","volume":"88","author":"Goedde","year":"1992","journal-title":"Hum. Genet."},{"key":"10.1016\/j.bone.2020.115370_bb0070","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1146\/annurev-pharmtox-010814-124915","article-title":"A personalized medicine approach for Asian Americans with the aldehyde dehydrogenase 2*2 variant","volume":"55","author":"Gross","year":"2015","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.bone.2020.115370_bb0075","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1002\/jbmr.1634","article-title":"Aldehyde-stress resulting from Aldh2 mutation promotes osteoporosis due to impaired osteoblastogenesis","volume":"27","author":"Hoshi","year":"2012","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2020.115370_bb0080","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s00223-017-0285-0","article-title":"Disruption of the aldehyde dehydrogenase 2 gene results in no increase in trabecular bone mass due to skeletal loading in association with impaired cell cycle regulation through p21 expression in the bone marrow cells of mice","volume":"101","author":"Okuma","year":"2017","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bone.2020.115370_bb0085","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.bone.2011.01.008","article-title":"Reduced bone formation in alcohol-induced osteopenia is associated with elevated p21 expression in bone marrow cells in aldehyde dehydrogenase 2-disrupted mice","volume":"48","author":"Shimizu","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.bone.2020.115370_bb0090","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.bone.2018.02.020","article-title":"Cortical bone loss due to skeletal unloading in aldehyde dehydrogenase 2 gene knockout mice is associated with decreased PTH receptor expression in osteocytes","volume":"110","author":"Tajima","year":"2018","journal-title":"Bone"},{"key":"10.1016\/j.bone.2020.115370_bb0095","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.bone.2012.12.049","article-title":"Disruption of aldehyde dehydrogenase 2 gene results in altered cortical bone structure and increased cortical bone mineral density in the femoral diaphysis of mice","volume":"53","author":"Tsuchiya","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.bone.2020.115370_bb0100","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S0014-5793(00)01710-5","article-title":"Aldehyde dehydrogenase (ALDH) 2 associates with oxidation of methoxyacetaldehyde; in vitro analysis with liver subcellular fraction derived from human and Aldh2 gene targeting mouse","volume":"476","author":"Kitagawa","year":"2000","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bone.2020.115370_bb0105","doi-asserted-by":"crossref","first-page":"951","DOI":"10.2741\/1589","article-title":"Tissue-distribution of aldehyde dehydrogenase 2 and effects of the ALDH2 gene-disruption on the expression of enzymes involved in alcohol metabolism","volume":"10","author":"Oyama","year":"2005","journal-title":"Front. Biosci."},{"key":"10.1016\/j.bone.2020.115370_bb0110","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1186\/s12891-018-2231-3","article-title":"Phospholipase C signaling activated by parathyroid hormone mediates the rapid osteoclastogenesis in the fracture healing of orchiectomized mice","volume":"19","author":"Li","year":"2018","journal-title":"BMC Musculoskelet. Disord."},{"key":"10.1016\/j.bone.2020.115370_bb0115","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.bone.2008.05.010","article-title":"The anabolic action of intermittent PTH in combination with cathepsin K inhibitor or alendronate differs depending on the remodeling status in bone in ovariectomized mice","volume":"44","author":"Yamane","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.bone.2020.115370_bb0120","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/j.bone.2007.02.001","article-title":"Contributions of parathyroid hormone (PTH)\/PTH-related peptide receptor signaling pathways to the anabolic effect of PTH on bone","volume":"40","author":"Yang","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.bone.2020.115370_bb0125","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.bone.2018.10.009","article-title":"Findings as a starting point to unravel the underlying mechanisms of in vivo interactions involving Wnt10a in bone, fat and muscle","volume":"120","author":"Tsukamoto","year":"2019","journal-title":"Bone"},{"key":"10.1016\/j.bone.2020.115370_bb0130","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/jbmr.141","article-title":"Guidelines for assessment of bone microstructure in rodents using micro-computed tomography","volume":"25","author":"Bouxsein","year":"2010","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2020.115370_bb0135","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jbmr.1805","article-title":"Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee","volume":"28","author":"Dempster","year":"2013","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2020.115370_bb0140","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.bone.2008.04.022","article-title":"Climbing exercise enhances osteoblast differentiation and inhibits adipogenic differentiation with high expression of PTH\/PTHrP receptor in bone marrow cells","volume":"43","author":"Menuki","year":"2008","journal-title":"Bone"},{"key":"10.1016\/j.bone.2020.115370_bb0145","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1210\/en.2007-0826","article-title":"CBP\/p300-interacting protein CITED1 modulates parathyroid hormone regulation of osteoblastic differentiation","volume":"149","author":"Yang","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2020.115370_bb0150","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1007\/s00198-006-0077-2","article-title":"ALDH2 polymorphisms and bone mineral density in an elderly Japanese population","volume":"17","author":"Yamaguchi","year":"2006","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2020.115370_bb0155","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/s41598-017-00503-2","article-title":"A missense single nucleotide polymorphism in the ALDH2 gene, rs671, is associated with hip fracture","volume":"7","author":"Takeshima","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bone.2020.115370_bb0160","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s00223-016-0151-5","article-title":"The relationship of BMD increases between the first 12 months and the latter 12 months by daily teriparatide treatment","volume":"99","author":"Niimi","year":"2016","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bone.2020.115370_bb0165","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.jos.2016.11.022","article-title":"Efficacy and safety of teriparatide in bisphosphonate-pretreated and treatment-naive patients with osteoporosis at high risk of fracture: post hoc analysis of a prospective observational study","volume":"22","author":"Yoshiki","year":"2017","journal-title":"J. Orthop. Sci."},{"key":"10.1016\/j.bone.2020.115370_bb0170","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1080\/03007995.2017.1354826","article-title":"Real-world effectiveness of daily teriparatide in Japanese patients with osteoporosis at high risk for fracture: final results from the 24-month Japan Fracture Observational Study (JFOS)","volume":"33","author":"Soen","year":"2017","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.bone.2020.115370_bb0175","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1359\/jbmr.081215","article-title":"Sequential treatment of severe postmenopausal osteoporosis after teriparatide: final results of the randomized, controlled European Study of Forsteo (EUROFORS)","volume":"24","author":"Eastell","year":"2009","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2020.115370_bb0180","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1210\/jc.2013-1172","article-title":"Teriparatide for idiopathic osteoporosis in premenopausal women: a pilot study","volume":"98","author":"Cohen","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2020.115370_bb0185","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1210\/jc.2013-4440","article-title":"Two years Denosumab and teriparatide administration in postmenopausal women with osteoporosis (The DATA Extension Study): a randomized controlled trial","volume":"99","author":"Leder","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2020.115370_bb0190","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s00774-011-0314-4","article-title":"Effects of teriparatide in Japanese and non-Japanese populations: bridging findings on pharmacokinetics and efficacy","volume":"30","author":"Tsujimoto","year":"2012","journal-title":"J. Bone Miner. Metab."},{"key":"10.1016\/j.bone.2020.115370_bb0195","article-title":"Control of bone mass and remodeling by PTH receptor signaling in osteocytes","volume":"3","author":"O\u2019Brien","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.bone.2020.115370_bb0200","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1002\/jbmr.304","article-title":"PTH receptor signaling in osteocytes governs periosteal bone formation and intracortical remodeling","volume":"26","author":"Rhee","year":"2011","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2020.115370_bb0205","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/jbmr.5650090707","article-title":"Stimulation of signal transduction pathways in osteoblasts by mechanical strain potentiated by parathyroid hormone","volume":"9","author":"Carvalho","year":"1994","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2020.115370_bb0210","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s002230001115","article-title":"Parathyroid hormone modulates the response of osteoblast-like cells to mechanical stimulation","volume":"67","author":"Ryder","year":"2000","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bone.2020.115370_bb0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0211076","article-title":"Loss of the PTH\/PTHrP receptor along the osteoblast lineage limits the anabolic response to exercise","volume":"14","author":"Gardinier","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.bone.2020.115370_bb0220","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/jbmr.3011","article-title":"Control of bone anabolism in response to mechanical loading and PTH by distinct mechanisms downstream of the PTH receptor","volume":"32","author":"Delgado-Calle","year":"2017","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2020.115370_bb0225","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1359\/jbmr.2002.17.9.1570","article-title":"Insulin-like growth factor I is required for the anabolic actions of parathyroid hormone on mouse bone","volume":"17","author":"Bikle","year":"2002","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2020.115370_bb0230","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.bone.2005.03.018","article-title":"SOST is a target gene for PTH in bone","volume":"37","author":"Keller","year":"2005","journal-title":"Bone"},{"key":"10.1016\/j.bone.2020.115370_bb0235","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.bone.2012.09.016","article-title":"Effects of PTH on osteocyte function","volume":"54","author":"Bellido","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.bone.2020.115370_bb0240","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/ejhg.2011.184","article-title":"Genome-wide association study of coronary artery disease in the Japanese","volume":"20","author":"Takeuchi","year":"2012","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.bone.2020.115370_bb0245","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.2147\/TCRM.S88297","article-title":"Aldehyde dehydrogenase-2 protects against myocardial infarction-related cardiac fibrosis through modulation of the Wnt\/\u03b2-catenin signaling pathway","volume":"11","author":"Zhao","year":"2015","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.bone.2020.115370_bb0250","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1359\/jbmr.2003.18.5.818","article-title":"p21(WAF1\/CIP1) acts as a brake in osteoblast differentiation","volume":"18","author":"Bellosta","year":"2003","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2020.115370_bb0255","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1074\/jbc.M409846200","article-title":"Parathyroid hormone uses multiple mechanisms to arrest the cell cycle progression of osteoblastic cells from G1 to S phase","volume":"280","author":"Qin","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2020.115370_bb0260","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.bone.2006.01.145","article-title":"Combined treatment with a beta-blocker and intermittent PTH improves bone mass and microarchitecture in ovariectomized mice","volume":"39","author":"Pierroz","year":"2006","journal-title":"Bone"},{"key":"10.1016\/j.bone.2020.115370_bb0265","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1302\/2046-3758.61.BJR-2016-0085.R1","article-title":"Parathyroid hormone 1-34 and skeletal anabolic action: the use of parathyroid hormone in bone formation","volume":"6","author":"Osagie-Clouard","year":"2017","journal-title":"Bone Joint Res"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328220301502?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328220301502?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T17:48:39Z","timestamp":1757612919000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328220301502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":53,"alternative-id":["S8756328220301502"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2020.115370","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disruption of the aldehyde dehydrogenase 2 gene increases the bone anabolic response to intermittent PTH treatment in an ovariectomized mouse model","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2020.115370","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115370"}}